Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Pfizer
Mayo Clinic
Replimune Inc.
Werewolf Therapeutics, Inc.
ModernaTX, Inc.
M.D. Anderson Cancer Center
AbbVie
AgonOx, Inc.
UNC Lineberger Comprehensive Cancer Center
Novartis
Inhibrx Biosciences, Inc
AstraZeneca
Tesaro, Inc.
Bristol-Myers Squibb
Sensei Biotherapeutics, Inc.
Milton S. Hershey Medical Center
Novartis
BioAtla, Inc.
DEKA Biosciences
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
Checkpoint Therapeutics, Inc.
Immunophotonics, Inc.
Melanoma and Skin Cancer Trials Limited
Salubris Biotherapeutics Inc
ENB Therapeutics, Inc
Blackwell Device Consulting
Oslo University Hospital